New AstraZeneca vaccine trial likely: CEO

New AstraZeneca vaccine trial likely: CEO

SBS

Published

AstraZeneca is facing tricky questions about its success rate that some experts say could hinder its chances of getting speedy US and EU regulatory approval.

Full Article